Brush Up on Biosimilars

January 2025

You’ll see more Rxs for biosimilars...now that there are over 60 available in the US. And over 16 were approved in 2024 alone.

For example, there are now several biosimilars approved for ustekinumab (Stelara)...with ustekinumab-kfce (Yesintek) being the latest.

Keep in mind, biosimilars aren’t generics. It’s not possible to create an exact copy of the original reference product...since biologics contain larger, more complex molecules than most traditional drugs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote